Literature DB >> 22834393

Antibiotics in the treatment of peri-implantitis.

Arie Jan van Winkelhoff1.   

Abstract

PURPOSE: To review and discuss current literature on the use of systemically administered or locally delivered antibiotics in the treatment of peri-implantitis.
MATERIALS AND METHODS: A literature search was conducted using MEDLINE through the PubMed database of the US National Library of Medicine using studies up to 2011. Studies on the microbiology of peri-implantitis lesions were hand selected. RESULTS AND
CONCLUSIONS: Two studies on the use of systemically administered antibiotics in the treatment of peri-implantitis were identified. Both studies involved a case series without controls. Five studies on locally delivered antibiotics were found. In all cases, local antibiotics were used in conjunction with mechanical debridement and chemical disinfection with antimicrobial agents such as chlorhexidine digluconate or hydrogen peroxide. The additional effects of local antibiotics were noted in all studies but were in general moderate. This may in part be due to the selection of patients with advanced deep pockets and advanced bone loss. The current available scientific information on the use of locally or systemically administered antibiotics is insufficient to allow any firm specific recommendations for the use of these drugs. Local application of minocycline or doxycycline as an adjunct to mechanical debridement and irrigation with an antimicrobial agent may be effective in moderately deep lesions. Surgical access by full-thickness flap surgery in deeper lesions is probably necessary to halt the progression of bone loss. No sound scientific basis is available for the use of systemic antibiotics. There is an urgent need for randomised clinical trials on the use of antibiotics in the treatment of peri-implantitis. Proper periodontal infection control in dentate patients before implants are installed and frequent supportive implant care represent effective measures to reduce the risk of future infections and their complications around oral implants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22834393

Source DB:  PubMed          Journal:  Eur J Oral Implantol        ISSN: 1756-2406            Impact factor:   3.123


  13 in total

1.  Effects of enamel matrix derivative on non-surgical management of peri-implant mucositis: a double-blind randomized clinical trial.

Authors:  Atabak Kashefimehr; Reza Pourabbas; Masumeh Faramarzi; Ali Zarandi; Abouzar Moradi; Howard C Tenenbaum; Amir Azarpazhooh
Journal:  Clin Oral Investig       Date:  2016-12-30       Impact factor: 3.573

2.  Prevalence of antibiotic resistance genes in subjects with successful and failing dental implants. A pilot study.

Authors:  Georgios Koukos; Christos Papadopoulos; Lazaros Tsalikis; Dimitra Sakellari; Minas Arsenakis; Antonios Konstantinidis
Journal:  Open Dent J       Date:  2015-01-06

Review 3.  Surgical Non-Regenerative Treatments for Peri-Implantitis: a Systematic Review.

Authors:  Ausra Ramanauskaite; Povilas Daugela; Ricardo Faria de Almeida; Nikola Saulacic
Journal:  J Oral Maxillofac Res       Date:  2016-09-09

Review 4.  New approaches to combat Porphyromonas gingivalis biofilms.

Authors:  Evelien Gerits; Natalie Verstraeten; Jan Michiels
Journal:  J Oral Microbiol       Date:  2017-03-15       Impact factor: 5.474

Review 5.  Peri-Implant Diseases: Diagnosis, Clinical, Histological, Microbiological Characteristics and Treatment Strategies. A Narrative Review.

Authors:  Ioannis Kormas; Chantal Pedercini; Alessandro Pedercini; Michail Raptopoulos; Hatem Alassy; Larry F Wolff
Journal:  Antibiotics (Basel)       Date:  2020-11-22

Review 6.  Treatment Alternatives to Negotiate Peri-Implantitis.

Authors:  Eli E Machtei
Journal:  Adv Med       Date:  2014-06-15

7.  Scaling and root planning, and locally delivered minocycline reduces the load of Prevotella intermedia in an interdependent pattern, correlating with symptomatic improvements of chronic periodontitis: a short-term randomized clinical trial.

Authors:  Shuli Deng; Ying Wang; Wei Sun; Hui Chen; Gang Wu
Journal:  Ther Clin Risk Manag       Date:  2015-12-04       Impact factor: 2.423

8.  Antibacterial Peptide-Based Gel for Prevention of Medical Implanted-Device Infection.

Authors:  Mihaela Mateescu; Sébastien Baixe; Tony Garnier; Loic Jierry; Vincent Ball; Youssef Haikel; Marie Hélène Metz-Boutigue; Michel Nardin; Pierre Schaaf; Olivier Etienne; Philippe Lavalle
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

9.  Repurposing AM404 for the treatment of oral infections by Porphyromonas gingivalis.

Authors:  Evelien Gerits; Pieter Spincemaille; Kaat De Cremer; Katrijn De Brucker; Serge Beullens; Karin Thevissen; Bruno P A Cammue; Katleen Vandamme; Maarten Fauvart; Natalie Verstraeten; Jan Michiels
Journal:  Clin Exp Dent Res       Date:  2017-04-07

10.  Antimicrobial Activity of EPA and DHA against Oral Pathogenic Bacteria Using an In Vitro Multi-Species Subgingival Biofilm Model.

Authors:  Honorato Ribeiro-Vidal; María Carmen Sánchez; Andrea Alonso-Español; Elena Figuero; Maria José Ciudad; Luís Collado; David Herrera; Mariano Sanz
Journal:  Nutrients       Date:  2020-09-14       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.